[{"address1": "Three Bala Plaza East", "address2": "Suite 506", "city": "Bala Cynwyd", "state": "PA", "zip": "19004", "country": "United States", "phone": "844 511 9056", "website": "https://www.larimartx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carole S. Ben-Maimon M.D.", "age": 64, "title": "CEO, President & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 864999, "exercisedValue": 0, "unexercisedValue": 25808}, {"maxAge": 1, "name": "Mr. Michael  Celano CPA", "age": 64, "title": "Secretary & CFO", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 577579, "exercisedValue": 0, "unexercisedValue": 12903}, {"maxAge": 1, "name": "Dr. Gopi  Shankar M.B.A., Ph.D.", "age": 52, "title": "Chief Development Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 593020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Berman", "title": "Vice President of Finance & Administration", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer Spokes Johansson", "title": "Vice President of Legal & Compliance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Russell G. Clayton Sr., D.O, D.O.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Francis Michael Conway CPA", "title": "VP & Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.77, "open": 7.7, "dayLow": 7.67, "dayHigh": 9.03, "regularMarketPreviousClose": 7.77, "regularMarketOpen": 7.7, "regularMarketDayLow": 7.67, "regularMarketDayHigh": 9.03, "beta": 0.774, "forwardPE": -4.4278607, "volume": 1117281, "regularMarketVolume": 1117281, "averageVolume": 480316, "averageVolume10days": 280760, "averageDailyVolume10Day": 280760, "bid": 8.88, "ask": 8.94, "bidSize": 200, "askSize": 100, "marketCap": 567878720, "fiftyTwoWeekLow": 2.18, "fiftyTwoWeekHigh": 13.68, "fiftyDayAverage": 8.3088, "twoHundredDayAverage": 7.290225, "currency": "USD", "enterpriseValue": 275308512, "floatShares": 31925646, "sharesOutstanding": 63806600, "sharesShort": 3625059, "sharesShortPriorMonth": 3625213, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.056799997, "heldPercentInsiders": 0.0145000005, "heldPercentInstitutions": 1.08069, "shortRatio": 9.53, "shortPercentOfFloat": 0.087, "bookValue": 3.313, "priceToBook": 2.6863868, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -58338000, "trailingEps": -1.12, "forwardEps": -2.01, "lastSplitFactor": "1:12", "lastSplitDate": 1590710400, "enterpriseToEbitda": -4.203, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "LRMR", "underlyingSymbol": "LRMR", "shortName": "Larimar Therapeutics, Inc.", "longName": "Larimar Therapeutics, Inc.", "firstTradeDateEpochUtc": 1403184600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0bb9528f-7ec3-38bd-aa61-f67b2741ad55", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.9, "targetHighPrice": 36.0, "targetLowPrice": 14.0, "targetMeanPrice": 23.5, "targetMedianPrice": 25.0, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 226064000, "totalCashPerShare": 3.543, "ebitda": -65510000, "totalDebt": 5595000, "quickRatio": 10.722, "currentRatio": 10.926, "debtToEquity": 2.647, "returnOnAssets": -0.23587999, "returnOnEquity": -0.37476003, "freeCashflow": -22426250, "operatingCashflow": -42942000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]